Table 3 Significantly differential metabolites in serum of BDE-3 treated mice.
NO. | m/z | Ion | VIP | HMDB | Metabolite | Formula | aFC(0.0015) | FC(1.5) | FC(10) | FC(30) | Pathway | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.0015 | 1.5 | 10 | 30 | |||||||||||
1 | 116.071 | [M+H]+ | 1.85 | 1.62 | 1.34 | 1.37 | HMDB0000162 | L-Proline | C5H9NO2 | 1.46* | 1.65† | — | 1.51* | Arginine and proline metabolism |
2 | 118.086 | [M+H]+ | 2.43 | 2.58 | 1.93 | 2.05 | HMDB0000883 | L-Valine | C5H11NO2 | — | 1.51† | 1.41* | 1.47* | Valine, leucine and isoleucine degradation |
3 | 129.056 | [M−H]− | 0.81 | 1.38 | 1.46 | 1.86 | HMDB0000695 | Ketoleucine | C6H10O3 | — | 1.71* | 1.57* | 1.82† | Valine, leucine and isoleucine degradation |
4 | 130.087 | [M−H]− | 0.96 | 1.13 | 1.08 | 0.99 | HMDB0000687 | L-Leucine | C6H13NO2 | — | 1.58† | 1.46† | 1.39* | Valine, leucine and isoleucine degradation |
5 | 136.076 | [M+H]+ | 1.50 | 0.84 | 1.41 | 0.85 | HMDB0010715 | 2-Phenylacetamide | C8H9NO | 1.42† | 1.35* | 1.76† | 1.33* | Phenylalanine metabolism |
6 | 150.058 | [M+H]+ | 2.17 | 1.44 | 1.42 | 1.17 | HMDB0000696 | L-Methionine | C5H11NO2S | 1.34* | 1.33* | — | — | Cysteine and methionine metabolism |
7 | 157.061 | [M+H]+ | 1.28 | 0.89 | 0.56 | 1.22 | HMDB0001014 | 4-Imidazolone-5-propionic acid | C6H8N2O3 | 1.53‡ | 1.50* | 1.56† | 1.45† | Histidine metabolism |
8 | 162.112 | [M+H]+ | 1.55 | 0.61 | 1.01 | 1.57 | HMDB0000062 | L-Carnitine | C7H15NO3 | — | — | — | 1.34* | Lysine degradation |
9 | 164.071 | [M−H]− | 1.18 | 1.29 | 1.24 | 1.01 | HMDB0000159 | L-Phenylalanine | C9H11NO2 | 1.26* | 1.36† | 1.34† | 1.25* | Phenylalanine, tyrosine and tryptophan biosynthesis |
10 | 165.055 | [M+H]+ | 1.44 | 0.83 | 1.41 | 0.82 | — | L-Tyrosine fragment | C9H8O3 | 1.40† | 1.34* | 1.77† | 1.31* | |
11 | 172.991 | [M−H]− | 1.89 | 1.27 | 0.24 | 1.38 | — | Phenyl sulfate | C6H6O4S | 2.61* | 1.73* | — | 2.11* | |
12 | 182.081 | [M+H]+ | 3.61 | 1.93 | 3.34 | 1.94 | HMDB0000158 | L-Tyrosine | C9H11NO3 | 1.42† | 1.33* | 1.75† | 1.31* | Tyrosine metabolism |
13 | 185.154 | [M+H]+ | 1.45 | 1.34 | 1.39 | 1.50 | — | 2-hendecenoic acid | C11H20O2 | 1.92‡ | 2.28‡ | 2.29‡ | 2.44‡ | |
14 | 188.071 | [M+H]+ | 3.30 | 1.57 | 2.80 | 2.31 | — | L-Tryptophan fragment | C11H9NO2 | 1.25† | — | 1.32‡ | 1.24† | |
15 | 188.986 | [M−H]− | 1.21 | 1.35 | 0.32 | 1.16 | HMDB0059724 | Pyrocatechol sulfate | C6H6O5S | 1.87* | 2.10* | — | 1.91* | |
16 | 203.082 | [M−H]− | 1.68 | 0.74 | 1.46 | 1.05 | HMDB0000929 | L-Tryptophan | C11H12N2O2 | 1.19† | — | 1.20† | 1.12* | Phenylalanine, tyrosine and tryptophan biosynthesis |
17 | 212.002 | [M−H]− | 2.74 | 3.14 | 1.23 | 2.28 | — | Indoxylsulfuric acid | C8H7NO4S | 2.08† | 2.22† | — | 1.95* | |
18 | 225.123 | [M+NH4]+ | 1.62 | 1.13 | 0.68 | 1.56 | HMDB0000512 | N-Acetyl-L-phenylalanine | C11H13NO3 | 0.50† | 0.43† | — | 0.35‡ | Phenylalanine metabolism |
19 | 231.159 | [M+H]+ | 1.22 | 1.11 | 1.11 | 1.23 | HMDB0000623 | Dodecanedioic acid | C12H22O4 | 1.95‡ | 2.30‡ | 2.24‡ | 2.46‡ | |
20 | 267.073 | [M−H]− | 0.73 | 0.44 | 2.18 | 0.58 | HMDB0000195 | Inosine | C10H12N4O5 | — | — | 3.26‡ | — | Purine metabolism |
21 | 454.294 | [M+H]+ | 1.40 | 1.19 | 1.10 | 1.04 | HMDB0011473 | LysoPE(0:0/16:0) | C21H44NO7P | 1.27* | 1.44† | 1.32* | 1.30* | |
22 | 478.293 | [M−H]− | 0.63 | 1.31 | 1.10 | 0.72 | HMDB0011505 | LysoPE(18:1/0:0) | C23H46NO7P | — | 1.73† | 1.43† | — | Pentose and glucuronate interconversions |
23 | 478.294 | [M+H]+ | 0.16 | 2.91 | 2.18 | 0.58 | HMDB0011507 | LysoPE(18:2/0:0) | C23H44NO7P | — | 1.92‡ | 1.51† | — | |
24 | 494.325 | [M+H]+ | 4.34 | 2.99 | 3.84 | 2.74 | HMDB0010383 | LysoPC(16:1) | C24H48NO7P | 1.81‡ | 2.06* | 2.14‡ | 1.69† | Glycerophospholipid metabolism |
25 | 518.323 | [M+H]+ | 1.59 | 1.53 | 1.56 | 1.47 | HMDB0010387 | LysoPC(18:3) | C26H48NO7P | 1.09* | 1.16‡ | 1.15‡ | 1.14† | Pentose and glucuronate interconversions |
26 | 522.357 | [M+H]+ | 8.72 | 7.06 | 8.03 | 6.31 | HMDB0010385 | LysoPC(18:1) | C26H52NO7P | 1.49† | 1.74† | 1.76† | 1.52* | |
27 | 542.325 | [M+H]+ | 2.14 | 2.06 | 2.51 | 1.87 | HMDB0010397 | LysoPC(20:5/0:0) | C28H48NO7P | 1.44‡ | 1.94† | 1.97‡ | 1.63‡ | |
28 | 544.341 | [M+H]+ | 0.81 | 1.71 | 2.55 | 1.20 | HMDB0010396 | LysoPC(20:4) | C28H50NO7P | — | — | 1.20* | — | Glycerophospholipid metabolism |
29 | 546.357 | [M+H]+ | 2.17 | 1.86 | 3.03 | 2.53 | HMDB0010393 | LysoPC(20:3) | C28H52NO7P | — | 1.45* | 1.80† | 1.53† | Pentose and glucuronate interconversions |
30 | 570.356 | [M+H]+ | 1.14 | 1.05 | 1.39 | 1.04 | HMDB0010403 | LysoPC(22:5) | C30H52NO7P | — | 2.01† | 2.03† | — | Pentose and glucuronate interconversions |
31 | 619.288 | [M+Cl]- | 0.37 | 1.64 | 1.76 | 0.81 | HMDB0002577 | Cholic acid glucuronide | C30H48O11 | — | 1.89† | 1.84† | — | Pentose and glucuronate interconversions |